Genmab — Investor Relations & Filings
Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K - GENMAB A/S (0001434265) (Filer) | 2026-05-07 | English | |
| 6-K - GENMAB A/S (0001434265) (Filer) | 2026-04-17 | English | |
| 6-K - GENMAB A/S (0001434265) (Filer) | 2026-04-17 | English | |
| Genmab A/S Share Capital Reduction | 2026-04-17 | English | |
| Genmab A/S Share Capital Reduction | 2026-04-17 | English | |
| 6-K - GENMAB A/S (0001434265) (Filer) | 2026-04-14 | English |
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Genmab, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Bicara Therapeutics Inc.
Clinical-stage biopharma developing dual-action biologics f…
|
BCAX | US | Manufacturing |
|
BICYCLE THERAPEUTICS PLC
Clinical-stage biopharma developing a novel class of bicycl…
|
BCYC | GB | Manufacturing |
|
BIFIDO. Co. Ltd
Biotechnology firm developing human-derived Bifidobacterium…
|
238200 | KR | Manufacturing |
|
Binex Co., Ltd.
Biopharmaceutical firm with pharma manufacturing and biolog…
|
053030 | KR | Manufacturing |
|
BioAge Labs, Inc.
A clinical-stage biotech developing therapies for metabolic…
|
BIOA | US | Manufacturing |
|
Bioasis Technologies Inc.
Developing the xB3 platform to deliver therapeutics across …
|
BIOAF | CA | Manufacturing |
|
BioAtla, Inc.
Develops antibody-based therapeutics activated within the t…
|
BCAB | US | Manufacturing |
|
BIOBIJOU Co., Ltd.
Develops and manufactures medical aesthetic products like H…
|
489460 | KR | Manufacturing |
|
BioCardia, Inc.
Develops cell-derived therapeutics for cardiovascular and p…
|
BCDA | US | Manufacturing |
|
Biocartis Group NV
Develops and commercializes an automated molecular diagnost…
|
BCART | BE | Manufacturing |
Genmab via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/3365/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=3365 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=3365 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=3365 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 3365}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Genmab (id: 3365)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.